A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147

NCT05955872 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Focal Segmental Glomerulosclerosis (FSGS)

Interventions

DRUG: VX-147

Sponsor

Vertex Pharmaceuticals Incorporated